» Articles » PMID: 26964833

Crosstalk Between the Heart and Peripheral Organs in Heart Failure

Overview
Journal Exp Mol Med
Date 2016 Mar 12
PMID 26964833
Citations 41
Authors
Affiliations
Soon will be listed here.
Abstract

Mediators from peripheral tissues can influence the development and progression of heart failure (HF). For example, in obesity, an altered profile of adipokines secreted from adipose tissue increases the incidence of myocardial infarction (MI). Less appreciated is that heart remodeling releases cardiokines, which can strongly impact various peripheral tissues. Inflammation, and, in particular, activation of the nucleotide-binding oligomerization domain-like receptors with pyrin domain (NLRP3) inflammasome are likely to have a central role in cardiac remodeling and mediating crosstalk with other organs. Activation of the NLRP3 inflammasome in response to cardiac injury induces the production and secretion of the inflammatory cytokines interleukin (IL)-1β and IL-18. In addition to having local effects in the myocardium, these pro-inflammatory cytokines are released into circulation and cause remodeling in the spleen, kidney, skeletal muscle and adipose tissue. The collective effects of various cardiokines on peripheral organs depend on the degree and duration of myocardial injury, with systematic inflammation and peripheral tissue damage observed as HF progresses. In this article, we review mechanisms regulating myocardial inflammation in HF and the role of factors secreted by the heart in communication with peripheral tissues.

Citing Articles

p21-Activated Kinase 1 (Pak1) as an Element in Functional and Dysfunctional Interplay Among the Myocardium, Adipose Tissue, and Pancreatic Beta Cells.

Rosas P, Solaro R Compr Physiol. 2025; 15(2):e70006.

PMID: 40065530 PMC: 11894248. DOI: 10.1002/cph4.70006.


Skeletal Muscle Mass and Mortality in Heart Failure: Mediation Role of Systemic Immune-Inflammatory Index.

Cai X, Liu M, Qin P, Tang S, He L, Lei J JACC Adv. 2025; 4(2):101553.

PMID: 40014883 PMC: 11877227. DOI: 10.1016/j.jacadv.2024.101553.


Connecting intermediate phenotypes to disease using multi-omics in heart failure.

Moore A, Venkatesh R, Levin M, Damrauer S, Reza N, Cappola T Pac Symp Biocomput. 2024; 30:504-521.

PMID: 39670392 PMC: 11822568.


Organ crosstalk and dysfunction in sepsis.

Borges A, Bento L Ann Intensive Care. 2024; 14(1):147.

PMID: 39298039 PMC: 11413314. DOI: 10.1186/s13613-024-01377-0.


Immune mediators in heart-lung communication.

Gillan J, Jaeschke L, Kuebler W, Grune J Pflugers Arch. 2024; 477(1):17-30.

PMID: 39256247 PMC: 11711577. DOI: 10.1007/s00424-024-03013-z.


References
1.
Bujak M, Frangogiannis N . The role of IL-1 in the pathogenesis of heart disease. Arch Immunol Ther Exp (Warsz). 2009; 57(3):165-76. PMC: 2788964. DOI: 10.1007/s00005-009-0024-y. View

2.
Plater-Zyberk C, Joosten L, Helsen M, Siegfried C, Alouani S, van De Loo F . Therapeutic effect of neutralizing endogenous IL-18 activity in the collagen-induced model of arthritis. J Clin Invest. 2001; 108(12):1825-32. PMC: 209462. DOI: 10.1172/JCI12097. View

3.
Calogero Amato M, Giordano C . Visceral adiposity index: an indicator of adipose tissue dysfunction. Int J Endocrinol. 2014; 2014:730827. PMC: 4009335. DOI: 10.1155/2014/730827. View

4.
Adams V, Spate U, Krankel N, Schulze P, Linke A, Schuler G . Nuclear factor-kappa B activation in skeletal muscle of patients with chronic heart failure: correlation with the expression of inducible nitric oxide synthase. Eur J Cardiovasc Prev Rehabil. 2003; 10(4):273-7. DOI: 10.1097/00149831-200308000-00009. View

5.
Listing J, Strangfeld A, Kekow J, Schneider M, Kapelle A, Wassenberg S . Does tumor necrosis factor alpha inhibition promote or prevent heart failure in patients with rheumatoid arthritis?. Arthritis Rheum. 2008; 58(3):667-77. DOI: 10.1002/art.23281. View